Economics and Benefits Analysis

News & Updates

Thank you for being a member of the Economics and Benefits Analysis Specialty Group of the Society for Risk Analysis! We have several important updates for you.

New EBASG Executive Committee 2026: It is our pleasure to announce Sandra Hoffmann from George Washington University as Chair, Joseph Njau from U.S. Food and Drug Administration as Vice-Chair, and Annette Hofmann from University of Cincinnati as Secretary/Treasurer. They join Omer Keskin from University at Albany as Immediate Past Chair and Ernani Choma from Harvard University, and Aliya Sassi from U.S. FDA, as Past-Chair. Feel free to contact any of us with your ideas, questions, suggestions, or concerns. We look forward to hearing from you! 

EBASG is putting together an organized session for the 2026 SRA Annual Conference expected to be held later this year in December in Atlanta, GA. If you have ideas for some interesting theme that will bring diverse Benefit and Cost Analysis experts, please, do not hesitate to reach out to EBASG executive committee.